SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2728262959> ?p ?o ?g. }

Showing items 1 to 100 of ±127 with 100 items per page.

W2728262959 abstract "Podocalyxin (PODXL) is expressed in several cancers, including brain tumors and colorectal cancers. PODXL overexpression is an independent predictor of progression, metastasis, and poor outcome. We recently immunized mice with recombinant human PODXL, which was produced using LN229 glioblastoma cells, and produced a clone PcMab-47 that could be used for investigating PODXL expression by flow cytometry and immunohistochemical analysis. Herein, we produced a human-mouse chimeric PcMab-47 (chPcMab-47) and investigated its antitumor activity against PODXL-expressing tumors. chPcMab-47 reacted with LN229, LN229/PODXL, and Chinese hamster ovary (CHO)/PODXL cells, but it did not react with CHO-K1 or PODXL-knockout LN229 cell line (PDIS-13). chPcMab-47 exerted antitumor activity against a mouse xenograft model using CHO/PODXL. Furthermore, chPcMab-47 was reactive with colorectal cancer cell lines such as HCT-15, Caco-2, HCT-8, and DLD-1. chPcMab-47 also exhibited antitumor activity against a mouse xenograft model using HCT-15. These results suggest that chPcMab-47 could be useful for antibody therapy against PODXL-expressing cancers." @default.
W2728262959 created "2017-07-14" @default.
W2728262959 creator A5000775867 @default.
W2728262959 creator A5004870901 @default.
W2728262959 creator A5005708651 @default.
W2728262959 creator A5016361449 @default.
W2728262959 creator A5016375050 @default.
W2728262959 creator A5018371636 @default.
W2728262959 creator A5025137523 @default.
W2728262959 creator A5026376260 @default.
W2728262959 creator A5032655219 @default.
W2728262959 creator A5034011259 @default.
W2728262959 creator A5039225511 @default.
W2728262959 creator A5046301056 @default.
W2728262959 creator A5060363731 @default.
W2728262959 creator A5064054143 @default.
W2728262959 creator A5067408189 @default.
W2728262959 creator A5071892047 @default.
W2728262959 creator A5077624041 @default.
W2728262959 date "2017-08-01" @default.
W2728262959 modified "2023-10-17" @default.
W2728262959 title "Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas" @default.
W2728262959 cites W1891799992 @default.
W2728262959 cites W1898027227 @default.
W2728262959 cites W1968563619 @default.
W2728262959 cites W1972042205 @default.
W2728262959 cites W1979204476 @default.
W2728262959 cites W1981012330 @default.
W2728262959 cites W1982930403 @default.
W2728262959 cites W2002305744 @default.
W2728262959 cites W2036906023 @default.
W2728262959 cites W2042021736 @default.
W2728262959 cites W2064406354 @default.
W2728262959 cites W2075177133 @default.
W2728262959 cites W2083858386 @default.
W2728262959 cites W2092498705 @default.
W2728262959 cites W2094027801 @default.
W2728262959 cites W2098567941 @default.
W2728262959 cites W2098818191 @default.
W2728262959 cites W2101120866 @default.
W2728262959 cites W2112965812 @default.
W2728262959 cites W2112975932 @default.
W2728262959 cites W2132002425 @default.
W2728262959 cites W2154305402 @default.
W2728262959 cites W2159098596 @default.
W2728262959 cites W2160936126 @default.
W2728262959 cites W2167889022 @default.
W2728262959 cites W2256872475 @default.
W2728262959 cites W2346613849 @default.
W2728262959 cites W2430814939 @default.
W2728262959 cites W2613816154 @default.
W2728262959 doi "https://doi.org/10.1089/mab.2017.0020" @default.
W2728262959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28665782" @default.
W2728262959 hasPublicationYear "2017" @default.
W2728262959 type Work @default.
W2728262959 sameAs 2728262959 @default.
W2728262959 citedByCount "5" @default.
W2728262959 countsByYear W27282629592017 @default.
W2728262959 countsByYear W27282629592018 @default.
W2728262959 countsByYear W27282629592019 @default.
W2728262959 countsByYear W27282629592020 @default.
W2728262959 crossrefType "journal-article" @default.
W2728262959 hasAuthorship W2728262959A5000775867 @default.
W2728262959 hasAuthorship W2728262959A5004870901 @default.
W2728262959 hasAuthorship W2728262959A5005708651 @default.
W2728262959 hasAuthorship W2728262959A5016361449 @default.
W2728262959 hasAuthorship W2728262959A5016375050 @default.
W2728262959 hasAuthorship W2728262959A5018371636 @default.
W2728262959 hasAuthorship W2728262959A5025137523 @default.
W2728262959 hasAuthorship W2728262959A5026376260 @default.
W2728262959 hasAuthorship W2728262959A5032655219 @default.
W2728262959 hasAuthorship W2728262959A5034011259 @default.
W2728262959 hasAuthorship W2728262959A5039225511 @default.
W2728262959 hasAuthorship W2728262959A5046301056 @default.
W2728262959 hasAuthorship W2728262959A5060363731 @default.
W2728262959 hasAuthorship W2728262959A5064054143 @default.
W2728262959 hasAuthorship W2728262959A5067408189 @default.
W2728262959 hasAuthorship W2728262959A5071892047 @default.
W2728262959 hasAuthorship W2728262959A5077624041 @default.
W2728262959 hasConcept C121608353 @default.
W2728262959 hasConcept C134018914 @default.
W2728262959 hasConcept C153911025 @default.
W2728262959 hasConcept C175656101 @default.
W2728262959 hasConcept C185592680 @default.
W2728262959 hasConcept C2777146197 @default.
W2728262959 hasConcept C2779561371 @default.
W2728262959 hasConcept C2780091579 @default.
W2728262959 hasConcept C2781156571 @default.
W2728262959 hasConcept C502942594 @default.
W2728262959 hasConcept C526805850 @default.
W2728262959 hasConcept C54355233 @default.
W2728262959 hasConcept C553184892 @default.
W2728262959 hasConcept C81885089 @default.
W2728262959 hasConcept C86803240 @default.
W2728262959 hasConceptScore W2728262959C121608353 @default.
W2728262959 hasConceptScore W2728262959C134018914 @default.
W2728262959 hasConceptScore W2728262959C153911025 @default.
W2728262959 hasConceptScore W2728262959C175656101 @default.
W2728262959 hasConceptScore W2728262959C185592680 @default.
W2728262959 hasConceptScore W2728262959C2777146197 @default.